Sp391
PANEL DISCUSSION
Date
May 7, 2023
Explore related products in the following collection:
Tracks
Related Products
LONG-TERM SAFETY OF 3 YEARS OF OZANIMOD IN MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: AN INTERIM ANALYSIS OF THE TRUE NORTH OPEN-LABEL EXTENSION
BACKGROUND AND AIMS: A treat-to-target (TTT) strategy of striving for symptomatic and endoscopic remission is recommended for the management of inflammatory bowel diseases (IBD). Yet, real-world uptake of TTT strategies has been modest…
STATE-OF-THE-ART: CAN WE MOVE THE NEEDLE IN CRC SCREENING IN UNDER REPRESENTED MINORITIES
BACKGROUND: Although colorectal cancer (CRC) screening has been recommended for decades, about one-third of eligible individuals are not up-to-date with screening in the US. The COVID-19 pandemic has worsened this situation…
IMPACT OF STATE MEDICAID EXPANSION STATUS ON COLORECTAL CANCER SCREENING RATES AND PREDICTORS OF SCREENING AT U.S. FEDERALLY QUALIFIED HEALTH CENTERS
BACKGROUND: Although colorectal cancer (CRC) screening has been recommended for decades, about one-third of eligible individuals are not up-to-date with screening in the US. The COVID-19 pandemic has worsened this situation…
COLORECTAL CANCER SCREENING RATES AT FEDERALLY QUALIFIED HEALTH CENTERS IN THE UNITED STATES FROM 2020 TO 2021: INCOMPLETE REBOUND AND WORSENING DISPARITIES
BACKGROUND: Although colorectal cancer (CRC) screening has been recommended for decades, about one-third of eligible individuals are not up-to-date with screening in the US. The COVID-19 pandemic has worsened this situation…